Malignant Colon Neoplasm — Trials

Malignant Colon Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 117
Ph III recruiting: 18
Growth YoY: −3.8%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 26.9%
Trials / 1,000 deaths: 5.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (139)

clinicaltrialsPublishedShowing 101–107 of 107 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01126450	Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer	terminated	Phase 1	3	Case Comprehensive Cancer CenterOTHER	1	Mar 20, 2012	clinicaltrials
NCT00532987	Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer	terminated	—	22	Stanford UniversityOTHER	1	Feb 28, 2012	clinicaltrials